Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amag Pharmaceuticals (NQ: AMAG )

13.75 USD UNCHANGED
Last Price Updated: 4:06 PM EST, Nov 13, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Amag Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
AMAG Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for AMAG
In trading on Friday, shares of AMAG Pharmaceuticals, Inc. (AMAG) crossed above their 200 day moving average of $11.02, changing hands as high as $11.18 per share.. 
Tags Stocks
From Market News Video
12 Biotech Stocks Primed For A Short Squeeze
Biotech investment is fraught with risk. Most biotech stocks are at the mercy of binary events, which serve as make-or-break catalysts. ... 
Tags Biotech AKCA HRTX
From Benzinga
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG
From GlobeNewswire News Releases
Analysts Predict 11% Upside For The Holdings of VIOO
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Interesting AMAG Put And Call Options For January 2020
Investors in AMAG Pharmaceuticals, Inc. (AMAG) saw new options become available today, for the January 2020 expiration.. 
Tags Stocks
From Market News Video
AMAG Pharmaceuticals Inc (AMAG) Q3 2019 Earnings Call Transcript
AMAG earnings call for the period ending September 30, 2019. 
Tags Market News AMAG
From Motley Fool
AMAG Pharmaceuticals' Q3 Results Overshadowed by Ominous FDA Panel Recommendation
The drugmaker's Q3 results didn't matter very much in light of the prospect that it might have to yank Makena from the market. 
Tags AMAG Market News
From Motley Fool
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG
From GlobeNewswire News Releases
The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TRVI Contracts BMY
From Benzinga
AMAG Pharmaceuticals Announces Third Quarter 2019 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
28 Biggest Movers From Yesterday
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 65.6% to close at $3.56. Big 5 Sporting Goods Corporation (NASDAQ: BGFV) ... 
Tags IPHI TENB BDC
From Benzinga
Mid-Afternoon Market Update: Energy Stocks Fall 2%; US Fed Cuts Interest Rates
Toward the end of trading Wednesday, the Dow traded up 0.07% to 27,089.85, while the NASDAQ fell 0.03% to 8,274.08. The S&P also ... 
Tags MDU Eurozone CYCN
From Benzinga
Mid-Day Market Update: Oil Falls As US Inventory Rises; Big 5 Sporting Goods Spikes On Q3 Beat, Higher Guidance
Midway through trading on Wednesday, the Dow traded up 0.02% to 27,077.41 while the NASDAQ fell 0.05% to 8,271.74. The S&P also ... 
Tags News PCG GDOT
From Benzinga
28 Stocks Moving In Wednesday's Mid-Day Session
Gainers Shares of Big 5 Sporting Goods Corporation (NASDAQ: BGFV) spiked 32.8% to $3.20, after th4e company reported a ... 
Tags Mid/Day Movers MAT BGFV
From Benzinga
Biotech Dives After Panel Votes To Pull Its Drug Following Faulty Test
Shares of Amag Pharmaceuticals collapsed Wednesday after a split Food and Drug Administration advisory committee voted 9-7 to pull its preterm birth prevention drug, Makena, from the market. 
From Investor's Business Daily
Why AMAG Pharmaceuticals Is Tanking Today
Shares tumble after an FDA advisory committee recommends pulling one of the company's key drugs from the market. Here are the must-know details. 
Tags Market News AMAG
From Motley Fool
Amag Pharmaceuti Falling Today on Above-Average Volume (AMAG)
Amag Pharmaceuti's stock is down 7.7% to $10.00 on heavy trading volume. Approximately 1.9 million shares have changed hands today vs. average 30-day volume of 690,000 shares. Spikes... 
From Comtex SmarTrend® News Briefs
Amag Pharmaceuti Bearish Moving Average Crossover Alert (AMAG)
Amag Pharmaceuti (NASDAQ:AMAG) shares have crossed bearishly below their 10-day moving average of $11.80 on a volume of 1.9 million shares. Swing traders may find an opportunity for a... 
From Comtex SmarTrend® News Briefs
Benzinga's Top Upgrades, Downgrades For October 30, 2019
Upgrades For Analog Devices Inc (NASDAQ: ADI), Raymond James upgraded the stock from Market Perform to Outperform. In the third ... 
Tags MAN Benzinga NUS
From Benzinga
Amag Pharmaceuticals downgraded to Underweight from Neutral at Piper Jaffray
Piper Jaffray analyst Christoper Raymond downgraded Amag Pharmaceuticals to Underweight from Neutral with a price target of $6, down from $9. 
Tags Stocks / Equities
From Blogs - TalkMarkets
AMAG Pharmaceuticals Falls 25% After FDA Recommends Removing Makena From The Market
Shares of small-cap biotech AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) are crashing Wednesday morning. Adcom Shocker AMAG said the ... 
Tags AMAG General Trading Ideas
From Benzinga
10 Biggest Price Target Changes For Wednesday
Benchmark cut the price target for Grubhub Inc. (NYSE: GRUB) from $90 to $42. Grubhub shares closed at $33.11 on Tuesday. Stifel ... 
Tags AMAG CR Price Target Changes
From Benzinga
The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags Market News EYEN HZNP
From Benzinga
PRESS DIGEST -Wall Street Journal - Oct 30
The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. 
Tags companyNews
From Reuters: Company News
AMAG Reports on FDA Advisory Committee Meeting for Makena® (Hydroxyprogesterone Caproate Injection)
Company to Comment During Third Quarter Financial Results Conference Call on Friday, November 1, 2019, at 8:00 a.m. ET 
From GlobeNewswire News Releases
The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags CTMX DFFN ORGS
From Benzinga
AMAG Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss the Results of the Makena PROLONG Trial
From GlobeNewswire News Releases
Stocks Showing Improving Market Leadership: AMAG Pharmaceuticals Earns 87 RS Rating
AMAG Pharmaceuticals sees its Relative Strength Rating hit the 80-plus level. 
From Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.